Therapeutic Gene Editing Companies
This is the first comprehensive list of companies that are developing therapies with technologies that edit genes inside cells (namely CRISPR-, ZFN-, TALEN- based technologies). This dataset is compiled by Alexey Bersenev MD PhD from public information sources.
For each company:
- Company name
- Link to company website
- Country of origin
- Key partner or licensee
- Stage of development (preclinical or clinical)
- Gene Editing Technology (CRISPR-, ZFN-, TALEN-, etc.)
- Type of edit (ex vivo/in vivo)
- Therapeutic area(s)
- Only companies that provide therapeutic gene editing.
- Companies developing gene editing therapy either in-house or via relationships, or that have assets (via licensing or partnership) with therapeutic products.
- Exclude companies selling gene editing tools and services.
- Exclude manufacturers of gene editing tools/reagents.
- 3rd update to 96 companies through Dec. 2020: 2 co's changed name, 1 country update, 5 updates partner/licensee, 2 updates therapeutic area, 3 updates gene editing system, 5 updates targeted cell, 10 stage of development
- 2nd update to 71 companies through Sept. 2019: 2 co's changed name, 2 updates partner/licensee, 1 update therapeutic area,
- 1st update to 60 companies through May 2019
- Database launched with 46 companies through the end of 2018
|SAMPLE Therapeutic Gene Editing Companies||9.57 KB|